Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.

Diego Martinez-UrbistondoAna HuertaDavid Navarro-GonzálezLaura Sánchez-IñigoAlejandro Fernandez-MonteroManuel F Landecho José Alfredo Martínez HernándezJuan C Pastrana-Delgado

Published in: European journal of clinical investigation (2023)

MAFLD interplay with MetS and PreDM might help to discriminate patient risk of T2DM in the clinical setting through metabolic remodelling-based phenotypes.

Keyphrases

glycemic control
metabolic syndrome
insulin resistance
blood glucose
type diabetes
adipose tissue
weight loss